Russia Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
Condition:   Breast Cancer Intervention:   Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8
Conditions:   Prostate Cancer;   Breast Cancer Intervention:   Drug: Intravenous injection of [99mTc]Tc-DB8 Sponsors:   Tomsk National Research Medical Center of the Russian Academy of Sciences;   Uppsala University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials

A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
Condition:   Breast Cancer Intervention:   Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8
Conditions:   Prostate Cancer;   Breast Cancer Intervention:   Drug: Intravenous injection of [99mTc]Tc-DB8 Sponsors:   Tomsk National Research Medical Center of the Russian Academy of Sciences;   Uppsala University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials

A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
Condition:   Breast Cancer Intervention:   Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8
Conditions:   Prostate Cancer;   Breast Cancer Intervention:   Drug: Intravenous injection of [99mTc]Tc-DB8 Sponsors:   Tomsk National Research Medical Center of the Russian Academy of Sciences;   Uppsala University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials

A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
Condition:   Breast Cancer Intervention:   Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8
Conditions:   Prostate Cancer;   Breast Cancer Intervention:   Drug: Intravenous injection of [99mTc]Tc-DB8 Sponsors:   Tomsk National Research Medical Center of the Russian Academy of Sciences;   Uppsala University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials